efinancial careers reported that in 2020, William Blair and other firms made interns full-time offers for after they graduate even before internships started.
Corporate
William Blair Highlighted In efinancial careers For Making Interns Full-Time Offers
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Mersana Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Mersana Therapeutics, Inc. (MRSN $0.57), whose lead program emiltatug ledadotin is an ADC that targets B7-H4; it is in Phase I development for TNBC. The company is also developing a HER2-targeted immune-stimulating ADC, XMT-2056, in a Phase I solid tumor study.
-
2024 Record Totals for Secondaries Point to Positive 2025 Momentum
Bullish predictions for the secondary market throughout 2024 proved accurate as volume hit record levels by yearend. Now, in 2025’s early weeks, market insiders remain optimistic—with expectations for continued LP- and GP-led growth.
-